These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10960160)

  • 1. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.
    Rosenberg DR; Benazon NR; Gilbert A; Sullivan A; Moore GJ
    Biol Psychiatry; 2000 Aug; 48(4):294-300. PubMed ID: 10960160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.
    Gilbert AR; Moore GJ; Keshavan MS; Paulson LA; Narula V; Mac Master FP; Stewart CM; Rosenberg DR
    Arch Gen Psychiatry; 2000 May; 57(5):449-56. PubMed ID: 10807485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbito-frontal cortex and thalamus volumes in the patients with obsessive-compulsive disorder before and after cognitive behavioral therapy.
    Atmaca M; Yildirim H; Yilmaz S; Caglar N; Mermi O; Korkmaz S; Akaslan U; Gurok MG; Kekilli Y; Turkcapar H
    Int J Psychiatry Med; 2018 Jul; 53(4):243-255. PubMed ID: 26740455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
    Fitzgerald KD; Moore GJ; Paulson LA; Stewart CM; Rosenberg DR
    Biol Psychiatry; 2000 Feb; 47(3):174-82. PubMed ID: 10682215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
    Mirza Y; O'Neill J; Smith EA; Russell A; Smith JM; Banerjee SP; Bhandari R; Boyd C; Rose M; Ivey J; Renshaw PF; Rosenberg DR
    J Child Neurol; 2006 Feb; 21(2):106-11. PubMed ID: 16566872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effects of Cognitive Behavioral Therapy on Planning and Prefrontal Cortex Function in Pediatric Obsessive-Compulsive Disorder.
    van der Straten A; Huyser C; Wolters L; Denys D; van Wingen G
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Apr; 3(4):320-328. PubMed ID: 29628064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.
    Smith EA; Russell A; Lorch E; Banerjee SP; Rose M; Ivey J; Bhandari R; Moore GJ; Rosenberg DR
    Biol Psychiatry; 2003 Dec; 54(12):1399-405. PubMed ID: 14675804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial.
    Meyer E; Shavitt RG; Leukefeld C; Heldt E; Souza FP; Knapp P; Cordioli AV
    Braz J Psychiatry; 2010 Mar; 32(1):20-9. PubMed ID: 20339731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive-behavioral therapy in obsessive-compulsive disorder].
    Cordioli AV
    Braz J Psychiatry; 2008 Oct; 30 Suppl 2():s65-72. PubMed ID: 19039446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
    Højgaard DRMA; Hybel KA; Ivarsson T; Skarphedinsson G; Becker Nissen J; Weidle B; Melin K; Torp NC; Valderhaug R; Dahl K; Mortensen EL; Compton S; Jensen S; Lenhard F; Thomsen PH
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):940-947.e1. PubMed ID: 29096776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.
    Schwartz JM; Stoessel PW; Baxter LR; Martin KM; Phelps ME
    Arch Gen Psychiatry; 1996 Feb; 53(2):109-13. PubMed ID: 8629886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings.
    Szeszko PR; MacMillan S; McMeniman M; Lorch E; Madden R; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR
    Neuropsychopharmacology; 2004 Apr; 29(4):826-32. PubMed ID: 14970831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.
    Vattimo EFQ; Barros VB; Requena G; Sato JR; Fatori D; Miguel EC; Shavitt RG; Hoexter MQ; Batistuzzo MC
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1607-1617. PubMed ID: 30972581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.
    Rosenberg DR; Amponsah A; Sullivan A; MacMillan S; Moore GJ
    J Child Neurol; 2001 Sep; 16(9):636-41. PubMed ID: 11575601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional magnetic resonance imaging during planning before and after cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    Huyser C; Veltman DJ; Wolters LH; de Haan E; Boer F
    J Am Acad Child Adolesc Psychiatry; 2010 Dec; 49(12):1238-48, 1248.e1-5. PubMed ID: 21093773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full remission and relapse of obsessive-compulsive symptoms after cognitive-behavioral group therapy: a two-year follow-up.
    Braga DT; Manfro GG; Niederauer K; Cordioli AV
    Braz J Psychiatry; 2010 Jun; 32(2):164-8. PubMed ID: 20658055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coercive and disruptive behaviors mediate group cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder.
    Schuberth DA; Selles RR; Stewart SE
    Compr Psychiatry; 2018 Oct; 86():74-81. PubMed ID: 30081210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle.
    Jiménez-Ponce F; Velasco-Campos F; Castro-Farfán G; Nicolini H; Velasco AL; Salín-Pascual R; Trejo D; Criales JL
    Neurosurgery; 2009 Dec; 65(6 Suppl):203-9; discussion 209. PubMed ID: 19934996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy.
    Benazon NR; Moore GJ; Rosenberg DR
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1279-85. PubMed ID: 14566164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive symptom dimensions: Association with comorbidity profiles and cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Højgaard DRMA; Hybel KA; Mortensen EL; Ivarsson T; Nissen JB; Weidle B; Melin K; Torp NC; Dahl K; Valderhaug R; Skarphedinsson G; Storch EA; Thomsen PH
    Psychiatry Res; 2018 Dec; 270():317-323. PubMed ID: 30290317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.